Table of Contents
<< Previous Issue | Oct 2002 (Vol: 2002, Issue: 29) | Next Issue >> |
- Section: Company Profile
-
Innogenetics NV
- Section: Distribution & Marketing
-
Ferrer to Distribute AVAX Vaccine in Europe/Latin America
-
Enzon to Acquire North American and Japanese Rights to Elan Drug
- Section: General
-
UK Oncology plc
-
The Licensing of University Technologies
-
Therapy Focus: Interferons
- Section: Licensing
-
KS Biomedix Secures European Deal Over TransMID™-R
-
Eli Lilly Licenses Amylin Diabetes Treatment in US$325 M Deal
-
Igeneon Licenses Cancer Vaccine from Novartis
-
Access Oncology Licenses Zentaris’ Anticancer Compound
- Section: Mergers & Acquisitions
-
Adherex Technologies to Merge with Oxiquant
-
GenStar Therapeutics and Vascular Genetics Announce Merger
- Section: Research & Development
-
Roche and Kosan to Co-develop Anticancer Drug
-
Chiron to use Serenex’s Proteome Mining™ Technology